论文部分内容阅读
近年来的研究已确定 β受体阻滞剂是慢性心力衰竭的标准治疗药物之一[1] 。而在我国风湿性心脏病心力衰竭的常见病因 ,β受体阻滞剂对风湿性心脏病心力衰竭的疗效如何。本文研究旨在长期追踪观察美托洛尔对风湿性心脏病心力衰竭的远期预后。1 资料与方法1.1 病例选择 6 0例
In recent years, studies have identified beta blockers as one of the standard treatment of chronic heart failure [1]. In our country, the common cause of heart failure in rheumatic heart disease, β-blockers on rheumatic heart disease, the effect of heart failure. This study aims to long-term follow-up observation of metoprolol on rheumatic heart disease, long-term prognosis. 1 Materials and Methods 1.1 Case Selection 60 cases